Effects of PD-L1 on immunosuppression of bacterial sepsis and its relevant mechanism

doi:10.12047/j.cjap.6112.2021.091

Abstract

Abstract: Objective: To investigate the expression of programmed death ligand-1 (PD-L1) in dendritic cells (DCS) and its related signaling pathway in lipopolysaccharide (LPS)-induced immunosuppression of bacterial sepsis.Methods: Stimulating with bacterial LPS, bone marrow-derived dendritic cells could induce T lymphocyte immunosuppression imitating bacterial sepsis model. The experiments were divided into 5 groups: control group, LPS group, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002)+LPS group, pyrrolidinedithiocarbamate(PDTC)+LPS group and LPS+anti-PD-L1 group with 6 multiple wells in each group. After mice bone marrow source monocytes were cultured with rmGM-CSF (10 ng/ml) and rmIL-4 (1 ng/ml) in 10% fetal bovine serum 1640 for 4 days, DCs cells were treated with with 10 ng/ml LPS for 12 h to obtain immunosuppressive cells with high expression of PD-L1. Pathway-inhibitors LY294002 (10 μmol/L) and PDTC (20 μmol/L) were used to block PI3K and NF-κB signals. Flow cytometry and confocal laser scanning microscopy were used to detect the PD-L1 expression and phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) signal activation on DCs. BrdU cell proliferation assay and γ-interferon enzyme-linked immunospot assay were used to detect ovalbumin specific T lymphocyte proliferation response and cytotoxic T cell response, respectively. Results: Compared with the control group, the percentage of PD-L1 positive cells and PD-L1 red fluorescence intensity of DCs were all increased(P＜0.01), while DCs- mediated T cell proliferation and γ-interferon spot-forming cell number were decreased (P＜0.01).PI3K inhibitor LY294002, NF-κB inhibitor PDTC and PD-L1 blocking antibody could significantly reverse the inhibition of DCs mediated T lymphocytes immunosuppression above (P＜0.01). Conclusion: PD-L1 was a key molecule that mediates immunosuppression in lipopolysaccharide induced bacterial sepsis. PI3K Signal and NF- κB signal were also involved in this immunosuppressive process.

Key words: bacterial sepsis, lipopolysaccharide, dendritic cells, PD-L1, PI3K-AKT signal

CLC Number:

R392

WANG Fang, YANG Mu-yu, WANG Bin, QU Zhen-li, HU Qing-ru. Effects of PD-L1 on immunosuppression of bacterial sepsis and its relevant mechanism[J]. CJAP, 2021, 37(6): 606-610.

References

[1] Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
[2] Hotchkiss RS, Opal S. Immunotherapy for sepsis--a new approach against an ancient foe[J]. N Engl J Med, 2010, 363(1): 87-89.
[3] Delano MJ, Ward PA. Sepsis-induced immune dysfunction: Can immune therapies reduce mortality[J]. J Clin Invest, 2016, 126(1): 23-31.
[4] Wang HW, Lu JY. Progress in immunomodulatory therapy for sepsis targeting dendritic cells[J]. Infection Inflammation Repair, 2015, 16(2): 119-120.
[5] 姚咏明, 刘双庆. 树突状细胞与脓毒性休克[J]. 实用休克杂志, 2019, 3(1): 1-4.
[6] 曲冰杰, 郭剑颖, 王宏伟. 脓毒症患者免疫紊乱中树突细胞与T细胞分化及表型研究[J]. 中国免疫学杂志, 2019, 35(12): 1487-1490.[7] Wu Y, Chung CS, Chen Y, et al. A novel role for programmed cell death receptor ligand-1(PD-L1) in sepsis-induced intestinal dysfunction[J]. Mol Med, 2016, 22: 830-840.
[8] Chang K, Svabek C, Vazquez-Guillamet C, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis[J]. Crit Care, 2014, 18(1): R3.
[9] Jin HJ, Sui HX, Gao FG, et al. Nicotine up-regulated 4-1BBL expression by activating Mek-PI3K pathway augments the efficacy of bone marrow-derived dendritic cell vaccination [J]. J Clin Immunol, 2013, 33(1): 246-254.
[10] Stark AK, Sriskantharajah S, Hessel EM, et al. PI3K inhibitors in inflammation, autoimmunity and cancer[J]. Curr Opin Pharmacol, 2015, 23: 82-91.
[11] Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit [J]. Mol Cell Biol, 1999, 19(7): 4798-4805.
[12] 周婷,史家欣,李小民. PI3K/Akt信号通路在脓毒症固有免疫中的作用[J]. 中华危重病急救医学杂志, 2018, 30(11): 1091-1093.
[13] Schwandt T, Schumak B, Gielen GH, et al. Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis[J]. EMBO J, 2012, 31(1): 201-213.
[14] Wang F, Wang YY, Li J, et al. Increased antigen presentation but impaired T cells priming after upregulation of interferon-beta induced by lipopolysaccharides is mediated by upregulation of B7H1 and GITRL[J]. PLoS ONE, 2014, 9(8): e105636.
[15] J Unsinger, AH Walton, T Blood, et al. OX40 agonistic antibody reverses immune suppression and improves survival in sepsis[J]. J Leukoc Biol, 2020: 1-12.
[16] 马瑜红, 梁婧洁, 刘润秋, 等. 封闭PD-L1对小鼠细菌脓毒血症免疫麻痹的研究[J]. 中华医院感染学杂志, 2018, 28(1): 10-13.
[17] Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock[J]. Nat Rev Dis Primers, 2016, 2: 16045.
[18] RS Hotchkiss, G Monneret, D Payen. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy[J]. Nat Rev Immunol, 2013, 13(12): 862-874.
[19] Wu H, Windmiller DA, Wang L, et al. YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide3-kinase binding motifs and tyrosine-based endocytic sorting signals[J]. J Biol Chem, 2003, 278: 40425-40428.